Skip Navigation



NDT Plus Advance Access published online on May 25, 2008
NDT Plus, doi:10.1093/ndtplus/sfn058
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
1/4/218    most recent
sfn058v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Eriguchi, R.
Right arrow Articles by Sato, Y.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl

Rieko Eriguchi1, Junko Umakoshi1, Yoshihiro Tominaga2 and Yuzuru Sato1

1 Sato Junkanki Hospital, Matsuyama
2 Department of Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan

Correspondence: Rieko Eriguchi, Asouda-cho 4-10-25, Matsuyama City, Ehime Prefecture 790-0952, Japan. Tel: +81-89-931-3355; Fax: +81-89-931-3431; E-mail: rieko-eriguchi@satohp.co.jp

Key Words: bone mineral density • cinacalcet • parathyromatosis • secondary hyperparathyroidism

Received for publication April 25, 2008. Accepted for publication April 28, 2008.

The first 10% of the full text of this article appears below.


   Introduction
 
Secondary hyperparathyroidism is a common complication for patients with end-stage renal disease (ESRD). When it progresses, it is associated with morbidity and mortality [1]. Phosphate binders and vitamin D can be used to prevent the progression of secondary hyperparathyroidism. However, these conservative treatments often fail to control severe hyperparathyroidism. In such cases, parathyroidectomy is required. Despite medical management after parathyroidectomy, persistent or recurrent hyperparathyroidism can occur. One of the causes of recurrent hyperparathyroidism is parathyromatosis, which has been described as multiple nodules or rests of hyperfunctioning parathyroid tissue that become evident following parathyroidectomy. We describe a female haemodialysis patient diagnosed with secondary hyperparathyroidism, which was probably caused by parathyromatosis. Treatment with cinacalcet, a calcimimetic agent, in combination with vitamin D was extremely effective.


   Case report
 
A 66-year-old . . . [Full Text of this Article]


   Discussion
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
H. Komaba and M. Fukagawa
Regression of parathyroid hyperplasia by calcimimetics--fact or illusion?
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 707 - 709.
[Full Text] [PDF]